Dermatology Times

JULY 8, 2024

Matthew Zirwas, MD, hosted a Case-Based Roundtable discussion to review 2 challenging cases of atopic dermatitis.

Dermatitis 41

Dermatitis Clinic 41

Dermatology Times

OCTOBER 13, 2023

Almirall presented new data on lebrikizumab at EADV related to clinical improvements and clinically-meaningful treatment responses among patients with atopic dermatitis.

Clinic 74

Clinic Dermatitis Treatments 74

Dermatology Times

JULY 16, 2024

Jenny Murase, MD, and Elizabeth Kiracofe, MD, highlighted key clinical considerations to optimize atopic dermatitis care for patients during pregnancy, prepregnancy, postpartum, and breastfeeding.

Clinic 41

Clinic Management Dermatitis 41

Dermatology Times

AUGUST 20, 2024

Jayme Heim, MSN, FNP-BC, presents a case study on managing atopic dermatitis in a 20-year-old female patient.

Dermatitis 36

Dermatitis Management Clinic 36

Dermatology Times

JUNE 13, 2024

An expert in the management of dermatological conditions shares insights on managing atopic dermatitis patients, discussing the real-world effectiveness and physician satisfaction with ruxolitinib cream as a treatment option, as well as its adoption among healthcare providers.

Dermatitis 36

Dermatitis Management Clinic Treatments 36

Dermatology Times

FEBRUARY 22, 2024

In a recent study, topical ruxolitinib improved clinical outcomes, itch, and patient quality of life.

Clinic 74

Clinic Dermatitis 74

First Derm

FEBRUARY 21, 2024

Eczema (Atopic Dermatitis) Eczema, also known as atopic dermatitis, is a common skin condition characterized by characterized by impaired skin barrier function, intense itching, recurrent eczematous lesions, and is often associated with other allergic conditions. [1] Contact dermatitis from metals, latex, chemicals.

Eczema 59

Eczema Dermatitis Management Medical 59

Dermatology Times

NOVEMBER 28, 2023

A phase 1 study found that RPT193 monotherapy led to greater improvements in clinical efficacy than treatment with a placebo.

Clinic 78

Clinic Dermatitis Treatments 78

Dermatology Times

APRIL 2, 2024

Paller shares early findings from the award winning poster on PEDISTAD trial and its clinical implication for children with atopic dermatitis.

Dermatitis 90

Dermatitis Clinic 90

Dermatology Times

AUGUST 20, 2024

A key opinion leader in the field of dermatology examines treatment strategies and medication sequencing for atopic and hand dermatitis in a 20-year-old female patient, focusing on clinical considerations and optimal management approaches.

Dermatitis 36

Dermatitis Management Clinic Medical 36

MedEsthetics

AUGUST 11, 2023

atopic dermatitis, acne, inflammatory conditions, skincare, acne treatment, peptide, medical aesthetics, clinical trials, phase 1 study, British journal of dermatology

Dermatitis 60

Dermatitis Skincare Clinic Medical 60

Dermatology Times

JULY 3, 2024

Drs Kiracofe and Murase provide clinical insights on treatment escalation practices for patients with atopic dermatitis who are pregnant.

Dermatitis 36

Dermatitis Treatments Management Clinic 36

The Dermatology Digest

APRIL 10, 2024

Sitryx Therapeutics plans to advance SYX-5219, an oral, targeted, disease-modifying anti-inflammatory therapy that targets pyruvate kinase M2 (PKM2), to the clinic. SYX-5219 will be Sitryx’s first candidate from its proprietary pipeline to progress to regulatory non-clinical studies to support a clinical trial authorization (CTA).

Clinic 36

Clinic Office Partnerships Dermatitis 36

Dermatology Times

JULY 3, 2024

Experts on atopic dermatitis weigh the risks and rewards of systemic treatments for pregnant patients and provide clinical insights on monitoring for adverse effects associated with dupilumab.

Dermatitis 36

Dermatitis Treatments Clinic 36

Dermatology Times

FEBRUARY 6, 2024

Researchers explored the efficacy of a multistep treatment strategy in a younger patient population.

Clinic 81

Clinic Dermatitis Treatments 81

Dermatology Times

JUNE 12, 2024

Researchers hypothesize that skin contact with e-cigarette fluids can trigger an inflammatory response.

Clinic 77

Clinic Dermatitis 77

Dermatology Times

SEPTEMBER 13, 2023

Nektar Therapeutics announced the promising and statistically significant results, which included meeting endpoints of BSA, DLQI and POEM in patients with atopic dermatitis.

Clinic 74

Clinic Dermatitis 74

Dermatology Times

APRIL 19, 2024

James Del Rosso, DO, Brad Glick, DO, MPH, FAAD, and Lisa Swanson, MD, FAAD, address the demand for non-steroidal treatment alternatives while navigating the individualization of data interpretation regarding these treatments.

Treatments 36

Treatments Clinic Dermatitis 36

Dermatology Times

MAY 30, 2024

Chovatiya was a lead author of the latest seborrheic dermatitis and roflumilast foam review published in the Journal of Clinical and Aesthetic Dermatology.

Dermatitis 78

Dermatitis Clinic Dermatology 78

The Dermatology Digest

FEBRUARY 14, 2024

Food and Drug Administration (FDA) has accepted Galderma’s Biologics License Applications for nemolizumab for the treatment of patients with prurigo nodularis (PN) and for adolescents and adults with moderate to severe atopic dermatitis (AD). Galderma is planning for multiple regulatory submissions in 2024.

Dermatitis 78

Dermatitis Clinic Safety Dermatology 78

Dermatology Times

DECEMBER 7, 2023

A patient returns to your clinic seeking systemic therapy for her AD while postpartum and breastfeeding. Test your knowledge on injectables.

Management 73

Management Dermatitis Injections Therapy 73

The Dermatology Digest

JANUARY 22, 2024

s ZORYVE topical foam, 0.3%, is now officially available for the treatment of seborrheic dermatitis. Food and Drug Administration (FDA) approved ZORYVE foam for the treatment of seborrheic dermatitis in individuals 9 years of age and older on December 15, 2023. Arcutis Biotherapeutics, Inc.’s

Dermatitis 78

Dermatitis Treatments Innovations Clinic 78

Dermatology Times

NOVEMBER 22, 2023

Connect Biopharma announced positive long-term data from its China pivotal trial.

Clinic 73

Clinic Dermatitis Treatments 73

Dermatology Times

JULY 13, 2024

A significant proportion of pediatric patients with AD achieved and maintained clinical remission with dupilumab, according to a poster presented at the SPD's annual meeting.

Dermatitis 57

Dermatitis Therapy Clinic 57

First Derm

MARCH 22, 2024

Eczema herpeticum Medically reviewed by The Dermatologists and written by Dr. Alexander Börve In A Nutshell What It Is : Skin infection marked by fever and clusters of itchy blisters, often complicating atopic dermatitis. Who’s at Risk : Affects both genders and all ages, but more common in infants and children with atopic dermatitis.

Eczema 52

Eczema Dermatitis Clinic Medical 52

Dermatology Times

JANUARY 2, 2024

A late breaking session from Revolutionizing Atopic Dermatitis Virtual Conference analyzed the frequency and clinical meaningfulness of conjunctivitis.

Dermatitis 74

Dermatitis Clinic 74

Dermatology Times

JANUARY 12, 2024

Ten posters at the Winter Clinical Hawaii and Maui Derm Conferences will showcase investigational data to expand treatment options for patients with atopic dermatitis and chronic hand eczema.

Eczema 74

Eczema Dermatitis Clinic Treatments 74

The Dermatology Digest

JUNE 4, 2024

Waldman Department of Dermatology and Professor of Dermatology and Immunology at the Icahn School of Medicine at Mount Sinai in New York City, received the Paul Ehrlich Award for Experimental Research at the 2024 European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress in Valencia, Spain.

Eczema 36

Eczema Dermatitis Clinic Sensitive Skin 36

The Dermatology Digest

JANUARY 14, 2024

People with seborrheic dermatitis who don’t use topical steroids are 3.5 The research was presented at the 2024 Winter Clinical Dermatology Conference – Hawaii in Honolulu. The research was presented at the 2024 Winter Clinical Dermatology Conference – Hawaii in Honolulu. Zoryve foam; 48.3% of the total study population).

Dermatitis 72

Dermatitis Dermatology Office Safety 72

The Dermatology Digest

AUGUST 13, 2024

Drawing upon their 2016 discovery that the interferon response is constantly activated in people with Down syndrome, researchers designed the trial to focus on the autoimmune and inflammatory skin conditions that are common in people with Down syndrome including alopecia areata, psoriasis, atopic dermatitis, and hidradenitis suppurativa.

Clinic 74

Clinic Safety Dermatitis Medical 74

Dermatology Times

FEBRUARY 9, 2024

Interim data from the clinical trial was presented in a poster at the South Beach Symposium, with itch reduction demonstrating immediacy and long-term capability.

Dermatitis 90

Dermatitis Clinic 90

The Dermatology Digest

FEBRUARY 26, 2024

Shared-decision making focused on weighing risks versus benefits is key when choosing the most appropriate systemic atopic dermatitis (AD) treatment for a patient, according to new research presented at the 2024 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Washington, DC. some of the JAK inhibitors).

Treatments 74

Treatments Dermatitis Pharmaceutical Clinic 74

Dermatology Times

JANUARY 30, 2024

Positive results in preclinical animal trials of DPT0218 may lead to advances in clinical treatment of autoimmune diseases.

Dermatitis 74

Dermatitis Clinic Treatments 74

Dermatology Times

APRIL 5, 2024

Researchers address the persisting gaps in managing mental health comorbidities within the framework of existing clinical practice guidelines.

Management 57

Management Dermatitis Clinic 57

The Dermatology Digest

APRIL 7, 2024

A newly developed therapeutic ladder can help guide dermatologists and patients on the use of nonsteroidal treatment options for atopic dermatitis (AD). Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago.

Treatments 77

Treatments Dermatitis Therapy Safety 77

The Dermatology Digest

JANUARY 4, 2024

Smoking is known to increase the risk of developing atopic dermatitis (AD), even in adolescents. Furthermore, adolescents who use e-cigarettes are at increased risk of developing the “atopic march” consisting of the triad of asthma, atopic dermatitis, and allergic and allergic rhinitis compared to non-smokers,” the study authors write.

Dermatitis 69

Dermatitis Dermatology Medical Education 69

Dermatology Times

JULY 2, 2024

Mona Shahriari, MD, presents a case study of a 12-year-old African American girl experiencing an intensely pruritic rash predominantly affecting the bilateral antecubital and popliteal fossae.

Clinic 36

Clinic Management Dermatitis 36